John Way
Analyst · William Blair. Please proceed with your question
Thank you, Vicki. Our detailed fourth quarter financial results begin on Page 11 of our presentation. As Vicki mentioned, fourth quarter revenue of $105.2 million represents a 2% sequential decline consistent with the seasonality patterns of our business. We served 18,157 unique product developers in the fourth quarter, down 3% sequentially. Turning to Slide 13, and our detailed income statement, our non-GAAP gross margin in the quarter was 51%, compared to 51.7% in the third quarter. The sequential gross margin decline was primarily due to increased compensation driven by the holidays in the fourth quarter. Turning to operating expenses. Our total non-GAAP operating expenses totaled $37.4 million in the quarter compared to $33.3 million in the third quarter. The majority of the sequential increase in operating expense was directly tied to Protolabs 2.0, as described in our guidance during the third quarter call. As a reminder, we were capitalizing the cost of resources working on the project prior to going live. As the system was placed in service, these costs were expensed representing a sequential increase in R&D expense of approximately $3 million. With the assets placed in service mid-quarter, we incurred $750,000 from depreciation during the fourth quarter. Quarterly depreciation will increase to approximately $1.5 million in Q1 and will remain at that level each quarter going forward. Additionally, our GAAP operating expenses included $427,000 of transaction costs in the quarter that did not relate to the ongoing operations of the business and had been adjusted out for non-GAAP purposes. On a GAAP reporting basis, net income totaled $9.6 million resulting in diluted earnings per share of $0.36. Adjusting for the after-tax cost of stock compensation, amortization of intangibles, non-recurring transaction expenses related to the acquisition of 3D Hubs, and unrealized foreign currency gains, our non-GAAP diluted earnings per share in the quarter were $0.50 representing a $0.13 per share decrease from the prior-year, and a sequential decrease was $0.17 per share. Breaking down a sequential change in earnings per share further, increased operating expenses related to Protolabs 2.0 launch represented a negative sequential impact of $0.11 per share. The impact of lower volume was $0.03 per share. The remaining $0.03 was driven by lower gross margin, and various changes in operating expenses and other income. Transitioning now to our full-year 2020 financial results, which begin on Slide 15, revenues of $434.4 million declined 5% compared to 2019. We served over 40,000 product developers during 2020, a decline of 15.7% compared to the prior-year. The number of product developers served was not correlated to revenue due to the mix of business with injection molding average order size greater than that of CNC machining. 2020 non-GAAP gross margin was 51% compared to 52% in 2019. The year-over-year decline in gross margin was primarily due to mix changes and the challenges to absorb fixed costs, while responding to the lower volume driven by the COVID-19 pandemic. Total non-GAAP operating expenses totaled $143.7 million in 2020, compared to $144.5 million in 2019. During 2020, we were able to manage our expense below prior-year levels and continue to invest in the future through Protolabs 2.0. Our R&D expense increased $3.7 million during the year, principally related to the expense recorded in the fourth quarter related to the launch of our system as previously discussed. This increase during the year was offset by reduced sales and marketing spend due to lower travel and converting to virtual Trade Shows and other innovative marketing tactics to engage customers, as well as other cost management activities including executive and board compensation reductions. 2020 GAAP net income was $50.9 million, resulting in diluted earnings per share of $1.89. Adjusting for the after-tax cost of stock compensation, amortization of intangibles, non-recurring transaction expenses and unrealized foreign currency gains, our non-GAAP diluted earnings per share in 2020 was $2.36, representing a $0.42 per share decrease from 2019. Breaking down the year-over-year impact on EPS, the expenses associated with the investment in Protolabs 2.0 represented a $0.11 year-over-year reduction in per share. Lower volumes driven by the global pandemic equated to a $0.12 per share impact. The impact of lower gross margin was $0.14 per share. The remainder of the year-over-year change in non-GAAP earnings per share was due to costs associated with adapting to the evolving work environment and maintaining our organizational structure to support the long-term opportunities for the business. Now turning to cash flow on Slide 18. We generated $107 million in cash from operations during 2020 compared to $116.1 million in 2019. Even during a challenging year, our business produced very strong free cash flow due to the digital nature of our manufacturing operations. These strong cash flows allow us to invest in the future growth of the business, including Protolabs 2.0, and our recent acquisition of 3D Hubs. Capital spend in 2020 was $47 million, including the completion of Protolabs 2.0, progress on the new facility in Germany to consolidate our 3D printing operations, and the facility expansion in our injection molding and CNC operations in the United Kingdom. On December 31, 2020, our cash and marketable securities balance was $221 million. In January, we funded $130 million cash portion of the closing consideration to acquire 3D Hubs with cash on hand. 2020 was the most difficult backdrop our businesses face. Yet we adapted, continued our strong cash flow generation, proceeded with investments to support the long-term growth of our business, and continue to have a very strong debt free balance sheet. I'll now turn the call over to Rob for an overview of our longer-term strategy and 2021 priorities.